BDC vs NOVT

Belden Inc. (BDC) shows a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. The stock trades above its Graham Number of $62.37 at $115.26, but below the analyst target of $144.40, suggesting growth expectations are priced in. Solid ROE of 18.41% and consistent earnings beats support quality, but bearish insider activity and weak technical trend weigh negatively. Relative to peers, BDC appears reasonably valued with stable growth, though elevated debt and lack of key financial data constrain confidence.

Novanta Inc. exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a very conservative debt profile (Debt/Equity 0.23). However, the company is severely overvalued based on deterministic metrics, with a current price of $128.85 dwarfing the Graham Number ($34.91) and Intrinsic Value ($11.61). While the earnings track record is stellar with consistent beats over 25 quarters, the massive trailing P/E of 87.65 and bearish insider selling by the CEO and CFO create significant valuation risk. The stock is currently a high-quality business trading at a speculative premium.